Zosano Pharma Corp (ZSAN) SEC Filing 8-K Material Event for the period ending Saturday, October 5, 2019

Zosano Pharma Corp

CIK: 1587221 Ticker: ZSAN

View differences made from one to another to evaluate Zosano Pharma Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Zosano Pharma Corp.


Assess how Zosano Pharma Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Zosano Pharma Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors



Material Contracts, Statements, Certifications & more

Zosano Pharma Corp provided additional information to their SEC Filing as exhibits

Ticker: ZSAN
CIK: 1587221
Form Type: 8-K Corporate News
Accession Number: 0001193125-19-264141
Submitted to the SEC: Tue Oct 08 2019 9:05:36 AM EST
Accepted by the SEC: Tue Oct 08 2019
Period: Saturday, October 5, 2019
Industry: Pharmaceutical Preparations
  1. Event for Officers
  2. Financial Exhibit
  3. Listing Status

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: